Compare RZLT & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | DPRO |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 169.4M |
| IPO Year | N/A | N/A |
| Metric | RZLT | DPRO |
|---|---|---|
| Price | $2.02 | $6.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $12.33 | ★ $15.67 |
| AVG Volume (30 Days) | ★ 12.2M | 1.4M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,335,758.00 |
| Revenue This Year | N/A | $56.53 |
| Revenue Next Year | N/A | $137.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $1.07 | $1.63 |
| 52 Week High | $11.46 | $14.40 |
| Indicator | RZLT | DPRO |
|---|---|---|
| Relative Strength Index (RSI) | 25.06 | 38.40 |
| Support Level | $1.07 | $6.26 |
| Resistance Level | $1.85 | $7.70 |
| Average True Range (ATR) | 0.64 | 0.62 |
| MACD | -0.94 | -0.08 |
| Stochastic Oscillator | 9.26 | 0.44 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.